Across Canada, too many patients with advanced prostate cancer are denied access to Radioligand Therapy (RLT)—a breakthrough in nuclear medicine offering renewed hope when other treatments have failed.
The Canadian Association of Nuclear Medicine (CANM) is proud to lead a national initiative uniting patients, physicians, and advocates to demand equitable, compassionate access to RLT—no matter where you live.
ABOUT US
The Canadian Association of Nuclear Medicine strives for excellence in the practice of diagnostic and therapeutic nuclear medicine by promoting the continued professional competence of nuclear medicine specialists, establishing guidelines of clinical practice, and encouraging biomedical research.
We work with all professionals in nuclear medicine to ensure that Canadians have access to the highest quality nuclear medicine services.
Our board members invest more than their time; they also lead in their respective field.
Access the latest Nuclear Medicine guidelines and recommendations, developed by leading experts in the field, to ensure high-quality patient care.
Members
Looking to be A Part of our Community
The CANM is “the voice” for nuclear medicine specialists in Canada and solely represents the interests of these specialists. Over the past years, the CANM has been active in promoting and defending the needs of Canadian nuclear medicine specialists, especially during the medical isotope crisis. It is only through your active support that we are able to continue with multiple endeavours at both the provincial and federal levels.
Awards to recognize and support, nuclear medicine specialist, residents and medical students.
Activities to help meet your educational needs and to obtain accredited CPD hours.
Resident Membership in the Association is FREE.
Sign Up
